|
注册号: Registration number: |
ChiCTR-ROC-17014082 |
|
最近更新日期: Date of Last Refreshed on: |
2017-12-21 16:34:29 |
|
注册时间: Date of Registration: |
2017-12-21 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
小肠菌群差异与肠易激综合征相关性研究 |
|
Public title: |
Study on the difference of small intestinal microbiota related to irritable bowel syndrome |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
小肠菌群差异与肠易激综合征相关性研究 |
|
Scientific title: |
Study on the difference of small intestinal microbiota related to irritable bowel syndrome |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
朱佩 |
研究负责人: |
朱佩 |
|
Applicant: |
Zhu Pei |
Study leader: |
Zhu Pei |
|
申请注册联系人电话: Applicant telephone: |
+86 18930170293 |
研究负责人电话:
Study leader's |
+86 18930170293 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhup124@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhup124@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市宜山路600号 |
研究负责人通讯地址: |
上海市宜山路600号 |
|
Applicant address: |
600 Yishan Road, Shanghai, China |
Study leader's address: |
600 Yishan Road, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市第六人民医院 |
||
|
Applicant's institution: |
Shanghai 6th People's Hospital |
||
|
研究负责人所在单位: |
上海市第六人民医院 |
||
|
Affiliation of the Leader: |
Shanghai 6th People's Hospital |
||
|
是否获伦理委员会批准: |
否 |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
朱佩 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhu Pei |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市宜山路600号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
600 Yishan Road, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
院级课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
院级课题 |
||||||||||||||||||||||
|
研究疾病: |
肠易激综合征 |
||||||||||||||||||||||
|
Target disease: |
Irritable Bowel Syndrome |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
病因学/相关因素研究 |
||||||||||||||||||||||
|
Study type: |
Cause/Relative factors study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
病例对照研究 |
||||||||||||||||||||||
|
Study design: |
Case-Control study |
||||||||||||||||||||||
|
研究目的: |
通过肠镜检查,收集60例IBS患者作为研究组,同时收集30名健康志愿者末端回肠部位的小肠液,进行菌群分析,从而更加全面地了解病因,同时借助肠道菌群的关系调节菌群失调,达到治疗肠道疾病的目的。 |
||||||||||||||||||||||
|
Objectives of Study: |
Through colonoscopy, 60 IBS patients small intestinal fluid will be collected from terminal ileum as the study group; as well 30 healthy volunteers small intestinal fluid will be collected. We will carry out the analysis of flora, in order to get more comprehensive understanding of the cause of IBS then to achieve the purpose of treating intestinal diseases. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)年龄<18岁,2)有腹部手术史,3)处于怀孕期或哺乳期,4)近2周内使用过膨胀剂、止泻药、解痉药、益生菌及抗菌药物 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) age <18 years old; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-01-01 00:00:00至 To 2020-10-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-01-01 00:00:00 至 To 2020-10-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机试验 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non random |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
发表文献 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Publication |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |